Zoetis (NYSE:ZTS) – Equities research analysts at Jefferies Group issued their Q1 2018 earnings estimates for shares of Zoetis in a research note issued to investors on Friday, April 13th. Jefferies Group analyst I. Hilliker forecasts that the company will earn $0.71 per share for the quarter. Jefferies Group has a “Buy” rating and a $96.00 price objective on the stock. Jefferies Group also issued estimates for Zoetis’ FY2018 earnings at $3.07 EPS, FY2019 earnings at $3.56 EPS, FY2020 earnings at $4.11 EPS, FY2021 earnings at $4.56 EPS and FY2022 earnings at $5.09 EPS.

How to Become a New Pot Stock Millionaire

A number of other equities research analysts have also recently issued reports on the stock. Credit Suisse Group lifted their price target on shares of Zoetis from $83.00 to $89.00 and gave the company an “outperform” rating in a research note on Thursday, April 5th. ValuEngine raised shares of Zoetis from a “hold” rating to a “buy” rating in a research note on Monday, April 2nd. Morgan Stanley cut shares of Zoetis from an “overweight” rating to an “equal weight” rating and set a $70.00 price target on the stock. in a research note on Monday, March 19th. They noted that the move was a valuation call. Barclays set a $77.00 price target on shares of Zoetis and gave the company a “hold” rating in a research note on Saturday, February 17th. Finally, Deutsche Bank lifted their price target on shares of Zoetis from $76.00 to $78.00 and gave the company a “hold” rating in a research note on Friday, February 16th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $80.89.

NYSE:ZTS opened at $84.40 on Monday. Zoetis has a 1-year low of $53.00 and a 1-year high of $85.73. The company has a market cap of $40,552.65, a PE ratio of 35.17, a PEG ratio of 1.87 and a beta of 0.96. The company has a quick ratio of 2.55, a current ratio of 3.85 and a debt-to-equity ratio of 2.77.

Zoetis (NYSE:ZTS) last posted its earnings results on Thursday, February 15th. The company reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.66 by $0.03. The firm had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.40 billion. Zoetis had a net margin of 16.28% and a return on equity of 65.96%. The business’s quarterly revenue was up 14.3% on a year-over-year basis. During the same period in the previous year, the firm earned $0.47 EPS.

Institutional investors and hedge funds have recently made changes to their positions in the business. Harel Insurance Investments & Financial Services Ltd. acquired a new stake in Zoetis during the 4th quarter worth $108,000. We Are One Seven LLC acquired a new stake in Zoetis during the 4th quarter worth $120,000. Premia Global Advisors LLC acquired a new position in shares of Zoetis during the 4th quarter valued at about $122,000. Icon Wealth Partners LLC acquired a new position in shares of Zoetis during the 4th quarter valued at about $127,000. Finally, Steward Partners Investment Advisory LLC acquired a new position in shares of Zoetis during the 3rd quarter valued at about $114,000. 92.33% of the stock is currently owned by institutional investors.

In other Zoetis news, EVP Roxanne Lagano sold 35,663 shares of Zoetis stock in a transaction on Wednesday, February 21st. The shares were sold at an average price of $81.02, for a total transaction of $2,889,416.26. Following the sale, the executive vice president now owns 49,919 shares of the company’s stock, valued at approximately $4,044,437.38. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Heidi C. Chen sold 37,453 shares of Zoetis stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $81.02, for a total transaction of $3,034,442.06. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 112,952 shares of company stock worth $9,219,843. 0.35% of the stock is currently owned by corporate insiders.

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 1st. Shareholders of record on Friday, April 20th will be paid a dividend of $0.126 per share. The ex-dividend date of this dividend is Thursday, April 19th. This represents a $0.50 annualized dividend and a yield of 0.60%. Zoetis’s dividend payout ratio (DPR) is presently 20.83%.

TRADEMARK VIOLATION WARNING: This report was originally posted by Daily Political and is the property of of Daily Political. If you are accessing this report on another publication, it was stolen and republished in violation of US & international copyright laws. The legal version of this report can be read at https://www.dailypolitical.com/2018/04/16/jefferies-group-weighs-in-on-zoetis-q1-2018-earnings-zts.html.

About Zoetis

Zoetis Inc discovers, develops, manufactures, and markets veterinary vaccines and medicines in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.

Earnings History and Estimates for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.